Author: Hajishengallis, George; Russell, Michael W.
Title: Innate Humoral Defense Factors Cord-id: 8myto026 Document date: 2015_3_13
ID: 8myto026
Snippet: Although innate immunity came into the research spotlight in the late 1990s when its instructive role in the adaptive immune response was recognized, innate humoral defense factors have a much older history. The exocrine secretions of the body contain a plethora of distinct soluble factors (lysozyme, lactoferrin, peroxidases, proline-rich proteins, histatins, etc.) that protect the body from mucosal microbial pathogens. More recent studies have established that the humoral arm of innate immunity
Document: Although innate immunity came into the research spotlight in the late 1990s when its instructive role in the adaptive immune response was recognized, innate humoral defense factors have a much older history. The exocrine secretions of the body contain a plethora of distinct soluble factors (lysozyme, lactoferrin, peroxidases, proline-rich proteins, histatins, etc.) that protect the body from mucosal microbial pathogens. More recent studies have established that the humoral arm of innate immunity contains a heterogeneous group of pattern-recognition molecules (e.g., pentraxins, collectins, and ficolins), which perform diverse host-defense functions, such as agglutination and neutralization, opsonization, control of inflammation, and complement activation and regulation. These pattern-recognition molecules, which act as functional predecessors of antibodies (“ante-antibodiesâ€), and the classic soluble innate defense factors form an integrated system with complementary specificity, action, and tissue distribution, and they are the subject of this chapter.
Search related documents:
Co phrase search for related documents- active site and additional specificity: 1
- active site and lung injury: 1, 2
- acute phase and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8
- acute phase and adaptive immune response activation: 1
- acute phase and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
- acute phase and adaptive immunity activation: 1
- acute phase and liver release: 1, 2
- acute phase and local inflammation: 1, 2
- acute phase and long pentraxin: 1
- acute phase and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute phase and low concentration: 1, 2, 3
- acute phase and low molecular weight: 1, 2, 3, 4, 5, 6, 7
- acute phase and low tendency: 1
- acute phase and lps binding: 1, 2
- acute phase and lps response: 1, 2, 3
- acute phase and lung epithelial cell: 1
- acute phase and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- acute phase and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- acute phase and lung surfactant: 1, 2
Co phrase search for related documents, hyperlinks ordered by date